And that started my efforts with regard to
drug pricing trying to figure out exactly why that was happening.
Not exact matches
Add one more name to the new slew of pharma companies
trying to counteract the public backlash to big
drug price increases: France's Sanofi, a $ 126 billion firm known for its flagship diabetes and vaccines units.
Still, he's taken on market inefficiencies, called for expanding access to biosimilars, is approving generics at a record pace and
trying to bring down
drug prices.
Since Marathon won an approval to treat a condition that afflicts fewer than 200,000 Americans per year and has a dearth of treatment options (rather than
trying to become an also - ran in the saturated steroid therapy field), it has carte blanche over the
drug's
pricing.
Wells Fargo Securities LLC's David Maris told clients in a note, «We believe that there is a high risk that healthcare and
drug pricing will be a key part of the midterm elections as well as the next presidential election, and we expect that the current administration will
try to blunt any criticism that it hasn't done enough with plans of its own before then.»
The «war on
drugs» is counterproductive, since it raises the
price of the
drugs, makes
drug trafficking more profitable, and thus encourages dealers to
try to sell more.
JL: As I was
trying to run through modern day boogie men, I kept coming back to Martin Shkreli [the guy convicted of
drug price gauging].
I think that unless you're going to
try and go after nonpublic information in biotech stocks, the first indicator that anybody who only has public information has that a new
drug is not going to make it through the FDA is the
price action, so you just can not invest in those things.